Indirect comparison of vedolizumab and adalimumab for biologic-naive patients with ulcerative colitis. [electronic resource]
Producer: 20200312Description: 178-187 p. digitalISSN:- 1502-7708
- Adalimumab -- therapeutic use
- Anti-Inflammatory Agents -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Biological Products -- therapeutic use
- Colitis, Ulcerative -- drug therapy
- Gastrointestinal Agents -- therapeutic use
- Humans
- Quality of Life
- Randomized Controlled Trials as Topic
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Meta-Analysis; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.